Page Tools:

Handbook of Diabetic Hypertension

Author(s): David S.H. Bell, MD, FACP, Clinical Professor of Medicine, University of Birmingham School of Medicine, Birmingham, Alabama
James H. O'Keefe Jr., MD, Professor of Medicine, University of Missouri at Kansas City, Mid-America Heart Institute, St. Lukes Hospital
George L. Bakris, MD, FASN, FAHA, Director, Hypertension/Clinical Research Center, Rush University Medical Center, Chicago, Illinois
Details:
  • ISBN-13: 9781890114633
  • Paperback    130 pages      © 2006
Price: International Sales $27.95 US List
Add to Cart

Overview

Handbook of Diabetic Hypertension incorporates the latest guidelines and trials into a practical, concise, authoritative guide to the diagnosis, evaluation, and management of hypertension in type 2 diabetes, the most prevalent form of the disease. Adjunctive measures to lower cardiac risk and improve cardiovascular prognosis are also described, including intensive control of glycemia and diabetic dyslipidemia.  

ShowTable of Contents

1.  Introduction

2.  Overview of Diabetes Mellitus
            Description
            Prevalence
            Classification
            Presentation
            Diagnosis
            Screening for Diabetes
            Management of Diabetes
            Natural History and Prognosis

3. 
 Overview of Diabetic Hypertension
               
Epidemiology
            Natural History
            Goals of Therapy
            Pathophysiology
            Approach to Diagnosis and Treatment
            Effect of Treatment
            Awareness, Treatment, and Control
            Prevention

4.  Approach to Management of Diabetic Hypertension
            Step 1.  Confirm the Diagnosis
                  Proper Measurement Technique
                  White-Coat and Pseudohypertension
                  Identify Other Cardiac Risk Factors
                  Ambulatory Blood Pressure Monitoring
            Step 2.  Evaluate the Patient Clinically
                  Assessment of Target Organ Damage
                  Detection of Secondary Hypertension
            Step 3.  Initiate Treatment
                  Blood Pressure Goals
                  Approach to Treatment
                  Therapeutic Lifestyle Changes
                  Optimizing Compliance

5.  Treatment of Diabetic Hypertension
            Blood Pressure Goals
            Therapeutic Lifestyle Changes
            Initial Drug Therapy
            Rapidity of Blood Pressure Lowering and Intensification of Drug Therapy

6.  Major Drug Classes Used for Diabetic Hypertension
            Angiotensin II Receptor Blockers
            ACE Inhibitors
            Diuretics
            Beta Blockers
            Calcium Antagonists
            Vasodilators

7.  Resistant Hypertension

8.  Secondary Hypertension

9.  Other Measures to Improve Cardiovascular Prognosis
            Cardiovascular Disease and Diabetes
            Intensive Glycemic Control
            Intensive Control of Diabetic Dyslipidemia
            Diet Modification
            Physical Activity
            Weight Control
            Smoking Cessation
            Psychosocial Risk Factor Reduction

10.  Metabolic Syndrome
            Definition
            Prevalence
            Presentation and Diagnosis
            Etiology
            Clinical Sequelae
                  Cardiovascular Disease
                  Type 2 Diabetes
                  Other Associated Conditions
            Management

References and Suggested Readings

Index


Back to top

ShowAbout the Author(s)

David S.H. Bell, MD, FACP-Clinical Professor of Medicine, University of Birmingham School of Medicine, Birmingham, Alabama

David S. H. Bell, MB, is Clinical Professor of Medicine at the University of Alabama at Birmingham, School of Medicine, and a leading authority on the prevention and treatment of type 2 diabetes. During his  distinguished career, he  has contributed more than 230 articles to the medical literature. He is an active researcher and has served as Director of the Endocrine Clinical Research Program at the University of Alabama Birmingham. Dr. Bell speaks nationally and internationally on the treatment of type 2 diabetes and its complications, and he is currently a member of the editorial boards of Endocrine Practice, Treatments in Endocrinology, Diabetes, and Obesity and Metabolism. He is a recipient of the Distinguished Clinician Award from the American College of Endocrinology for outstanding contribution as a master educator and clinician and the Seale Harris Award from the Southern Medical Association for outstanding contributions to diabetes research.   

Additional Titles by this Author

James H. O'Keefe Jr., MD-Professor of Medicine, University of Missouri at Kansas City, Mid-America Heart Institute, St. Lukes Hospital

James H. O'Keefe, Jr., M.D., is Director of Preventive Cardiology at the Mid America Heart Institute and Professor of Medicine at the University of Missouri in Kansas City. His postgraduate training included a cardiology fellowship at Mayo Clinic in Rochester, Minnesota. He has written 135 articles and 6 books on cardiovascular medicine, and he lectures extensively on the role of therapeutic lifestyle changes and drug therapy in cardiovascular risk reduction. He is actively involved in patient care. 

Additional Titles by this Author

George L. Bakris, MD, FASN, FAHA-Director, Hypertension/Clinical Research Center, Rush University Medical Center, Chicago, Illinois

Dr. Bakris has published over 470 articles and book chapters in the areas of diabetic kidney disease, hypertension and progression of nephropathy. He is the Editor or Co-Editor of eight books, in the areas of Kidney Disease Progression and Diabetes. He has also served as the co-principal investigator of an NIH Clinical Research training grant (K30) to train clinical researchers (1999-2004). He chaired the National Kidney Foundation Consensus report on blood pressure and impact on renal disease progression (2000) and served on many national guideline committees including: the Joint National Committee Writing Groups 6 & 7 writing committees (1997, 2003) and the JNC 7 executive committee (2003), the American Diabetes Association Clinical Practice Guideline Committee (2002-2004), the National Kidney Foundation (K-DOQI) Blood Pressure Guideline committee (2002-2004), the National Kidney Foundation (K-DOQI) Diabetes Guideline committee (2003-2005), and the NIH National High Blood Pressure Education Program Working Group on Hypertension and Renal Disease (1994). He also served as an expert-consultant to the Cardio-renal Advisory Board of the FDA (1993-2003). Dr. Bakris is also the past- president of the American College of Clinical Pharmacology (2000-2002) and the President-elect of the American Society of Hypertension (ASH). He is the current Editor of Am J Nephrology, the Hypertension Section Editor of Up-to-Date, andco-Editor of J Hum HypertensionDr. Bakris received his medical degree from the Chicago Medical School and completed residency in Internal Medicine at the Mayo Graduate School of Medicine where he also did a research fellowship in Physiology and Biophysics. He then completed fellowships in Nephrology and Clinical Pharmacology at the University of Chicago. From 1988 to 1991, he served as Director of Renal Research at the Ochsner Clinic and was a faculty member of Tulane University School of Medicine. He was also Professor and Vice Chairman of Preventive Medicine and Director of the Rush University Hypertension Center in Chicago, IL from 1993 until 2006. Currently, he is a Professor of Medicine and Director of the Hypertensive Diseases Unit in the Section of Endocrinology, Diabetes, Metabolism and Hypertension at the University of Chicago, Pritzker School of Medicine.

Additional Titles by this Author

Back to top